Neuronal acetylcholine receptor subunit alpha-4
Cross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Neuronal acetylcholine receptor subunit alpha-4 as ChEMBL target CHEMBL4457, mapped to UniProt O70174. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Why Neuronal acetylcholine receptor subunit alpha-4 matters
Neuronal acetylcholine receptor subunit alpha-4 is reviewed as Neuronal acetylcholine receptor subunit alpha-4 (UniProt O70174); the current evidence base includes 1 approved drug, 8 compounds, and 1 assay, with lead potency reaching pChEMBL 10.4.
Neuronal acetylcholine receptor subunit alpha-4 Sequence length is 629 aa.
Review this target as Neuronal acetylcholine receptor subunit alpha-4, mapped to UniProt O70174. Sequence length is 629 aa.
Protein source · UniProt accession via ChEMBL component mappingDisease relevance is not yet populated for this evidence card.
This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
ChEMBL target recordChEMBL currently tracks 1 approved drug, 8 compounds, and 1 assay for this target. The dominant activity type is IC50. CHEMBL6623 is the current potency anchor at pChEMBL 10.4.
Use CHEMBL6623 as the tractability anchor when discussing potency (pChEMBL 10.4).
Activity source · ChEMBL 36 via Core EngineStart with the right source
Pick the first block or linked source that matches the review question in front of you.
Start with the review rationale when you need to explain why Neuronal acetylcholine receptor subunit alpha-4 matters before drilling into raw source blocks.
Jump to Review RationaleGo back to the target snapshot when you need the naming and mapping contract behind UniProt O70174, not just the summarized rationale.
Open Protein ContextUse the target snapshot disease block when you need the disease program and supporting signals, not only the card summary.
Open Disease ContextSnapshot State
No project snapshot selected. Export uses the live evidence card state.
pChEMBL Activity Distribution
Top 5 Inhibitors (by pChEMBL)
| Structure | Compound | pChEMBL | Type | Phase |
|---|---|---|---|---|
|
|
No preferred name
CHEMBL6623
|
10.4 | IC50 | — |
|
|
No preferred name
CHEMBL72675
|
8.8 | IC50 | — |
|
|
No preferred name
CHEMBL71046
|
8.4 | IC50 | — |
|
|
No preferred name
CHEMBL3
|
8.2 | IC50 | Approved |
|
|
No preferred name
CHEMBL309804
|
8.1 | IC50 | — |
Approved Drugs
| Structure | Compound | First Approval |
|---|---|---|
|
|
NICOTINE
CHEMBL3
|
1984 |